WMSA
EBS icon

Weiss Multi-Strategy Advisers’s Emergent Biosolutions EBS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-9,050
Closed -$229K – 770
2014
Q1 		$229K Buy
+9,050
New +$229K ﹤0.01% 883

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Weiss Multi-Strategy Advisers's EBS Position: Q2 2014 in Review

Weiss Multi-Strategy Advisers sold out of Emergent Biosolutions (EBS) in Q2 2014, closing a stake of 9,050 shares — an estimated $229K sold.

Weiss Multi-Strategy Advisers first reported a position in EBS in Q1 2014 and held it in 1 quarter. The position peaked at $229K in Q1 2014. 160 funds tracked by Wall St. Rank hold EBS as of Q2 2014.

  • Weiss Multi-Strategy Advisers reported no remaining Emergent Biosolutions position as of Q2 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 9,050 Emergent Biosolutions shares in Q2 2014, an estimated $229K.
  • Weiss Multi-Strategy Advisers first reported a position in Emergent Biosolutions in Q1 2014 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Emergent Biosolutions position peaked at $229K in Q1 2014.
  • 160 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.